Clinical Trial Update: A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating CS1001 in patients with stage IV non-small cell lung cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CS1001

Snippet

Sponsor: CStone Pharmaceuticals | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING